Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: Q4QJ44
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 12 |
GO:0006694 | steroid biosynthetic process | 5 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0008202 | steroid metabolic process | 4 | 12 |
GO:0008610 | lipid biosynthetic process | 4 | 12 |
GO:0009058 | biosynthetic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 12 |
GO:1901576 | organic substance biosynthetic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity | 5 | 12 |
GO:0016229 | steroid dehydrogenase activity | 3 | 12 |
GO:0016491 | oxidoreductase activity | 2 | 12 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3 | 12 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 12 |
GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4 | 12 |
GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity | 5 | 1 |
GO:0047012 | sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity | 5 | 1 |
GO:0103066 | 4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity | 5 | 1 |
GO:0103067 | 4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity | 5 | 1 |
GO:0102294 | cholesterol dehydrogenase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 210 | 214 | PF00656 | 0.455 |
CLV_NRD_NRD_1 | 374 | 376 | PF00675 | 0.702 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.305 |
CLV_PCSK_KEX2_1 | 321 | 323 | PF00082 | 0.460 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.341 |
CLV_PCSK_PC1ET2_1 | 321 | 323 | PF00082 | 0.460 |
CLV_PCSK_SKI1_1 | 106 | 110 | PF00082 | 0.316 |
DEG_MDM2_SWIB_1 | 332 | 340 | PF02201 | 0.283 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.352 |
DOC_ANK_TNKS_1 | 123 | 130 | PF00023 | 0.516 |
DOC_PP1_RVXF_1 | 204 | 210 | PF00149 | 0.455 |
DOC_PP1_RVXF_1 | 22 | 29 | PF00149 | 0.455 |
DOC_PP1_RVXF_1 | 320 | 327 | PF00149 | 0.257 |
DOC_PP1_RVXF_1 | 342 | 348 | PF00149 | 0.337 |
DOC_PP2B_LxvP_1 | 183 | 186 | PF13499 | 0.455 |
DOC_PP4_FxxP_1 | 122 | 125 | PF00568 | 0.450 |
DOC_SPAK_OSR1_1 | 235 | 239 | PF12202 | 0.541 |
DOC_USP7_UBL2_3 | 224 | 228 | PF12436 | 0.541 |
DOC_USP7_UBL2_3 | 256 | 260 | PF12436 | 0.493 |
DOC_WW_Pin1_4 | 109 | 114 | PF00397 | 0.449 |
DOC_WW_Pin1_4 | 227 | 232 | PF00397 | 0.455 |
LIG_14-3-3_CanoR_1 | 206 | 215 | PF00244 | 0.455 |
LIG_APCC_ABBA_1 | 329 | 334 | PF00400 | 0.324 |
LIG_BRCT_BRCA1_1 | 113 | 117 | PF00533 | 0.467 |
LIG_deltaCOP1_diTrp_1 | 334 | 343 | PF00928 | 0.283 |
LIG_EH1_1 | 101 | 109 | PF00400 | 0.516 |
LIG_FHA_1 | 192 | 198 | PF00498 | 0.455 |
LIG_FHA_1 | 296 | 302 | PF00498 | 0.388 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.424 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.449 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.455 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.516 |
LIG_FHA_2 | 208 | 214 | PF00498 | 0.455 |
LIG_FHA_2 | 238 | 244 | PF00498 | 0.472 |
LIG_LIR_Apic_2 | 120 | 125 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 141 | 148 | PF02991 | 0.457 |
LIG_LIR_Gen_1 | 53 | 62 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 163 | 169 | PF02991 | 0.515 |
LIG_LIR_Nem_3 | 323 | 329 | PF02991 | 0.293 |
LIG_LIR_Nem_3 | 339 | 345 | PF02991 | 0.286 |
LIG_LIR_Nem_3 | 53 | 58 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 82 | 87 | PF02991 | 0.464 |
LIG_MAD2 | 24 | 32 | PF02301 | 0.455 |
LIG_Pex14_1 | 347 | 351 | PF04695 | 0.298 |
LIG_Pex14_2 | 332 | 336 | PF04695 | 0.282 |
LIG_Pex14_2 | 343 | 347 | PF04695 | 0.296 |
LIG_PTB_Apo_2 | 226 | 233 | PF02174 | 0.505 |
LIG_PTB_Phospho_1 | 226 | 232 | PF10480 | 0.505 |
LIG_SH2_CRK | 84 | 88 | PF00017 | 0.516 |
LIG_SH2_NCK_1 | 55 | 59 | PF00017 | 0.480 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.541 |
LIG_SH2_STAT5 | 232 | 235 | PF00017 | 0.375 |
LIG_SH2_STAT5 | 237 | 240 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 251 | 254 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 282 | 285 | PF00017 | 0.324 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.466 |
LIG_SH3_3 | 133 | 139 | PF00018 | 0.448 |
LIG_SH3_3 | 173 | 179 | PF00018 | 0.455 |
LIG_SH3_3 | 271 | 277 | PF00018 | 0.590 |
LIG_SH3_3 | 325 | 331 | PF00018 | 0.328 |
LIG_SH3_3 | 74 | 80 | PF00018 | 0.452 |
LIG_TYR_ITSM | 51 | 58 | PF00017 | 0.516 |
MOD_CDK_SPxxK_3 | 109 | 116 | PF00069 | 0.455 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.455 |
MOD_CK1_1 | 363 | 369 | PF00069 | 0.429 |
MOD_CK1_1 | 56 | 62 | PF00069 | 0.560 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.455 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.516 |
MOD_CK2_1 | 241 | 247 | PF00069 | 0.490 |
MOD_GlcNHglycan | 363 | 366 | PF01048 | 0.664 |
MOD_GlcNHglycan | 57 | 61 | PF01048 | 0.360 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.447 |
MOD_GSK3_1 | 237 | 244 | PF00069 | 0.446 |
MOD_N-GLC_1 | 117 | 122 | PF02516 | 0.372 |
MOD_N-GLC_1 | 336 | 341 | PF02516 | 0.598 |
MOD_N-GLC_2 | 214 | 216 | PF02516 | 0.341 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.446 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.324 |
MOD_NEK2_1 | 295 | 300 | PF00069 | 0.375 |
MOD_NEK2_1 | 307 | 312 | PF00069 | 0.243 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.476 |
MOD_PIKK_1 | 363 | 369 | PF00454 | 0.380 |
MOD_PKA_2 | 158 | 164 | PF00069 | 0.533 |
MOD_Plk_1 | 336 | 342 | PF00069 | 0.357 |
MOD_Plk_1 | 354 | 360 | PF00069 | 0.290 |
MOD_Plk_1 | 50 | 56 | PF00069 | 0.521 |
MOD_Plk_2-3 | 128 | 134 | PF00069 | 0.455 |
MOD_Plk_2-3 | 51 | 57 | PF00069 | 0.533 |
MOD_Plk_4 | 117 | 123 | PF00069 | 0.467 |
MOD_Plk_4 | 266 | 272 | PF00069 | 0.542 |
MOD_Plk_4 | 355 | 361 | PF00069 | 0.429 |
MOD_ProDKin_1 | 109 | 115 | PF00069 | 0.449 |
MOD_ProDKin_1 | 227 | 233 | PF00069 | 0.455 |
TRG_ENDOCYTIC_2 | 143 | 146 | PF00928 | 0.464 |
TRG_ENDOCYTIC_2 | 251 | 254 | PF00928 | 0.469 |
TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.467 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.452 |
TRG_ER_diArg_1 | 84 | 86 | PF00400 | 0.533 |
TRG_Pf-PMV_PEXEL_1 | 322 | 327 | PF00026 | 0.461 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6H3 | Leptomonas seymouri | 89% | 93% |
A0A0S4J083 | Bodo saltans | 67% | 92% |
A0A1X0NKS1 | Trypanosomatidae | 73% | 93% |
A0A3R7NBA3 | Trypanosoma rangeli | 72% | 93% |
A0A3S5H5P6 | Leishmania donovani | 98% | 93% |
A4H4K0 | Leishmania braziliensis | 92% | 100% |
A4HSS6 | Leishmania infantum | 98% | 93% |
A6NKP2 | Homo sapiens | 26% | 90% |
A8DZE7 | Danio rerio | 27% | 98% |
A9X4U2 | Arabidopsis thaliana | 27% | 67% |
B2FI29 | Stenotrophomonas maltophilia (strain K279a) | 28% | 100% |
C9ZTC5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 71% | 94% |
E9AKR3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
O35296 | Mesocricetus auratus | 22% | 100% |
O35469 | Mus musculus | 24% | 100% |
O43050 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 26% | 100% |
O46516 | Equus caballus | 22% | 100% |
O57245 | Vaccinia virus (strain Ankara) | 21% | 100% |
P14893 | Bos taurus | 21% | 100% |
P21097 | Vaccinia virus (strain Copenhagen) | 21% | 100% |
P22071 | Rattus norvegicus | 25% | 100% |
P24815 | Mus musculus | 24% | 100% |
P26149 | Mus musculus | 25% | 100% |
P26150 | Mus musculus | 25% | 100% |
P26670 | Vaccinia virus (strain Western Reserve) | 21% | 100% |
P27364 | Rattus norvegicus | 23% | 100% |
P53199 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 27% | 100% |
P75821 | Escherichia coli (strain K12) | 23% | 100% |
P9WN64 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 25% | 100% |
P9WN65 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 25% | 100% |
P9WQP6 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 27% | 100% |
P9WQP7 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 27% | 100% |
Q0IH73 | Xenopus laevis | 27% | 98% |
Q15738 | Homo sapiens | 32% | 100% |
Q32L94 | Bos taurus | 25% | 96% |
Q3ZBE9 | Bos taurus | 31% | 100% |
Q4R7R1 | Macaca fascicularis | 25% | 96% |
Q5A1B0 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 27% | 100% |
Q5PPL3 | Rattus norvegicus | 28% | 100% |
Q60555 | Mesocricetus auratus | 23% | 100% |
Q62878 | Rattus norvegicus | 24% | 100% |
Q64421 | Mesocricetus auratus | 23% | 100% |
Q67ZE1 | Arabidopsis thaliana | 31% | 67% |
Q8EG63 | Shewanella oneidensis (strain MR-1) | 25% | 98% |
Q8PDW5 | Xanthomonas campestris pv. campestris (strain ATCC 33913 / DSM 3586 / NCPPB 528 / LMG 568 / P 25) | 31% | 100% |
Q8WUS8 | Homo sapiens | 25% | 96% |
Q9D665 | Mus musculus | 27% | 96% |
Q9FX01 | Arabidopsis thaliana | 31% | 86% |
Q9H2F3 | Homo sapiens | 25% | 100% |
Q9N119 | Sus scrofa | 22% | 100% |
Q9R1J0 | Mus musculus | 28% | 100% |
Q9RR28 | Streptomyces antibioticus | 24% | 100% |
Q9XWF0 | Caenorhabditis elegans | 24% | 82% |
V5BEU6 | Trypanosoma cruzi | 71% | 93% |